Effectiveness of risk minimization measures for valproate: a drug utilization study based on implementation of a risk minimization programme in Europe, analysis of data from the UK-Reference-Cited by-同舟云学术

Effectiveness of risk minimization measures for valproate: a drug utilization study based on implementation of a risk minimization programme in Europe, analysis of data from the UK

Published:2022-01-08 Issue: Volume: Page:1-8
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Ehlken Birgit¹^ORCID,Nishikawa Chihiro²,Kaplan Sigal³^ORCID,Dresco Isabelle⁴,Granados Denis²^ORCID,Toussi Massoud⁵^ORCID

Affiliation:

1. Epidemiology and Safety, IQVIA, Munich, Germany

2. Research and Development, Sanofi R&D, Chilly-Mazarin, France

3. Pharmacovigilance, Teva Pharmaceutical Industries Ltd, Netanya, Israel

4. Research and Development, Sanofi, Paris, France

5. Real World Solutions, IQVIA, Courbevoie, France

Funder

Alfsigma SpA

Apotex Europe BV

Aristo Pharma GmbH

Arrow Generiques

Betapharm Arzneimittel GmbH

Biogaran

Demo SA

Desitin Arzneimittel GmbH

Generis Farmacêutica SA

GL Pharma GmbH

Hexal AG

Mylan EMEA SAS

Neuraxpharm Arzneimittel GmbH

Noridem Enterprises Ltd

Orion Corporation

Sanofi Aventis

Stada Arzneimittel AG

TAD Pharma GmbH

Tecnifar Indústria Técnica Farmacêutica SA

Temmler Pharma GmbH

Teva Pharmaceuticals Europe BV

Wockhardt UK Ltd,

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1997286

Reference17 articles.

1. NICE. Bipolar disorder: assessment and management. NICE Clinical Guidelines, No. 185 [Internet]. 2020 [cited 2020 Jun]. Available from: https://www.nice.org.uk/guidance/cg185

2. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

3. NICE. Epilepsies: diagnosis and management [Internet] [cited 2020 Jun]. Available from: https://www.nice.org.uk/guidance/cg137/chapter/1-Guidance#sodium-valproate

4. NICE. Bipolar disorder: assessment and management [Internet] [cited 2020 Jun]. Available from: https://www.nice.org.uk/guidance/cg185/chapter/1-Recommendations#managing-mania-or-hypomania-in-adults-in-secondary-care-2

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New valproate regulations, informed choice and seizure risk;Journal of Neurology;2024-06-19

2. Prenatal Exposure to Valproic Acid Across Various Indications for Use;JAMA Network Open;2024-05-22

3. Impact of Risk Minimisation Measures on Valproate Use among Women of Reproductive Age in Latvia Between 2013 and 2020: A 7-Year Nationwide Prescription Database Study;Drugs - Real World Outcomes;2023-10-12

4. Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study;Drug Safety;2023-06-09